US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist

6.020
-0.220-3.53%

Close May 1 16:00 ET

6.020
0.0000.00%

Post 16:00 ET

260.95MMarket Cap-5733P/E (TTM)

Werewolf Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

19.67%-32.61M

61.37%-4.59M

50.19%-7.21M

-3,504.29%-10.92M

29.05%-9.9M

5.32%-40.6M

6.34%-11.87M

-16.55%-14.47M

97.10%-303K

-90.43%-13.95M

Net income from continuing operations

30.56%-37.37M

-0.61%-12M

30.63%-8.29M

65.07%-5.1M

21.91%-11.98M

-7.66%-53.81M

33.24%-11.93M

13.19%-11.94M

-33.63%-14.59M

-106.36%-15.34M

Operating gains losses

----

--7K

----

Depreciation and amortization

59.78%1.76M

10.31%460K

10.15%445K

134.59%434K

333.67%425K

411.11%1.1M

768.75%417K

502.99%404K

198.39%185K

151.28%98K

Other non cash items

-59.43%878K

-29.57%455K

112.20%626K

-51.31%409K

-259.79%-612K

316.96%2.16M

5,772.73%646K

71.51%295K

394.12%840K

130.72%383K

Change In working capital

-332.14%-5.89M

256.84%4.63M

59.51%-2.09M

-174.82%-8.6M

119.54%163K

11.51%2.54M

-176.85%-2.95M

-1,269.76%-5.16M

2,181.34%11.49M

-31.34%-834K

-Change in receivables

180.51%5.58M

273.55%4.56M

148.85%1.02M

69.73%-672K

--673K

---6.93M

---2.63M

---2.08M

---2.22M

--0

-Change in prepaid assets

583.59%1.27M

-78.60%671K

60.27%-267K

87.15%-580K

-19.34%1.44M

91.47%-262K

583.22%3.14M

20.00%-672K

-62.88%-4.52M

2,108.64%1.79M

-Change in payables and accrued expense

-242.32%-4.34M

189.33%762K

-1,050.21%-2.27M

-161.59%-3.92M

140.44%1.09M

-51.42%3.05M

-122.61%-853K

-62.36%239K

157.69%6.37M

-345.63%-2.71M

-Change in other current assets

----

6,700.00%136K

101.49%18K

---18K

----

--2K

---1.21M

--0

-Change in other current liabilities

----

--0

---191K

----

--0

335.80%191K

--0

-Change in other working capital

-225.75%-8.4M

60.80%-1.42M

73.43%-705K

-126.74%-3.44M

-3,560.98%-2.84M

2,873.03%6.68M

-1,497.68%-3.62M

-1,442.44%-2.65M

7,717.75%12.87M

151.57%82K

Cash from discontinued investing activities

Operating cash flow

19.67%-32.61M

61.37%-4.59M

50.19%-7.21M

-3,504.29%-10.92M

29.05%-9.9M

5.32%-40.6M

6.34%-11.87M

-16.55%-14.47M

97.10%-303K

-90.43%-13.95M

Investing cash flow

Cash flow from continuing investing activities

78.70%-769K

61.78%-198K

88.69%-221K

83.62%-182K

-500.00%-168K

-625.10%-3.61M

-90.44%-518K

-1,815.69%-1.95M

-900.90%-1.11M

-115.38%-28K

Net PPE purchase and sale

78.70%-769K

61.78%-198K

88.69%-221K

83.62%-182K

-500.00%-168K

-625.10%-3.61M

-90.44%-518K

-1,815.69%-1.95M

-900.90%-1.11M

-115.38%-28K

Cash from discontinued investing activities

Investing cash flow

78.70%-769K

61.78%-198K

88.69%-221K

83.62%-182K

-500.00%-168K

-625.10%-3.61M

-90.44%-518K

-1,815.69%-1.95M

-900.90%-1.11M

-115.38%-28K

Financing cash flow

Cash flow from continuing financing activities

267.34%58.43M

622.37%9.07M

-99.63%41K

-79.74%692K

30,480.50%48.62M

-85.46%15.91M

3,205.26%1.26M

4,113.04%11.08M

-96.90%3.42M

129.55%159K

Net issuance payments of debt

--40M

--0

--40M

--0

Net common stock issuance

16.45%18.33M

807.25%8.88M

-99.47%59K

-81.52%675K

--8.71M

-85.90%15.74M

--979K

--11.11M

--3.65M

--0

Proceeds from stock option exercised by employees

-60.63%100K

100.00%48K

-97.14%2K

4,900.00%50K

--0

23.90%254K

-7.69%24K

159.26%70K

-99.24%1K

657.14%159K

Net other financing activities

----

80.39%-20K

---33K

---90K

96.30%-88K

2,008.33%253K

66.34%-102K

----

Cash from discontinued financing activities

Financing cash flow

267.34%58.43M

622.37%9.07M

-99.63%41K

-79.74%692K

30,480.50%48.62M

-85.46%15.91M

3,205.26%1.26M

4,113.04%11.08M

-96.90%3.42M

129.55%159K

Net cash flow

Beginning cash position

-17.82%130.53M

6.80%151.29M

7.93%158.68M

16.60%169.09M

-17.82%130.53M

71.20%158.83M

-17.51%141.66M

-20.33%147.01M

70.80%145.01M

71.20%158.83M

Current changes in cash

188.51%25.05M

138.54%4.29M

-38.09%-7.39M

-620.29%-10.41M

378.99%38.56M

-142.85%-28.3M

13.75%-11.13M

58.19%-5.35M

-97.99%2M

-75.45%-13.82M

End cash Position

19.19%155.58M

6.80%151.29M

7.93%158.68M

16.60%169.09M

-17.82%130.53M

-17.51%141.66M

-20.33%147.01M

70.80%145.01M

Free cash flow

24.49%-33.38M

61.39%-4.78M

54.77%-7.43M

-685.22%-11.1M

27.99%-10.07M

-1.92%-44.21M

4.30%-12.39M

-31.21%-16.43M

86.62%-1.41M

-90.48%-13.98M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	19.67%-32.61M	61.37%-4.59M	50.19%-7.21M	-3,504.29%-10.92M	29.05%-9.9M	5.32%-40.6M	6.34%-11.87M	-16.55%-14.47M	97.10%-303K	-90.43%-13.95M
Net income from continuing operations	30.56%-37.37M	-0.61%-12M	30.63%-8.29M	65.07%-5.1M	21.91%-11.98M	-7.66%-53.81M	33.24%-11.93M	13.19%-11.94M	-33.63%-14.59M	-106.36%-15.34M
Operating gains losses	----	----	----	----	----	--7K	----	----	----	----
Depreciation and amortization	59.78%1.76M	10.31%460K	10.15%445K	134.59%434K	333.67%425K	411.11%1.1M	768.75%417K	502.99%404K	198.39%185K	151.28%98K
Other non cash items	-59.43%878K	-29.57%455K	112.20%626K	-51.31%409K	-259.79%-612K	316.96%2.16M	5,772.73%646K	71.51%295K	394.12%840K	130.72%383K
Change In working capital	-332.14%-5.89M	256.84%4.63M	59.51%-2.09M	-174.82%-8.6M	119.54%163K	11.51%2.54M	-176.85%-2.95M	-1,269.76%-5.16M	2,181.34%11.49M	-31.34%-834K
-Change in receivables	180.51%5.58M	273.55%4.56M	148.85%1.02M	69.73%-672K	--673K	---6.93M	---2.63M	---2.08M	---2.22M	--0
-Change in prepaid assets	583.59%1.27M	-78.60%671K	60.27%-267K	87.15%-580K	-19.34%1.44M	91.47%-262K	583.22%3.14M	20.00%-672K	-62.88%-4.52M	2,108.64%1.79M
-Change in payables and accrued expense	-242.32%-4.34M	189.33%762K	-1,050.21%-2.27M	-161.59%-3.92M	140.44%1.09M	-51.42%3.05M	-122.61%-853K	-62.36%239K	157.69%6.37M	-345.63%-2.71M
-Change in other current assets	----	----	6,700.00%136K	101.49%18K	---18K	----	----	--2K	---1.21M	--0
-Change in other current liabilities	----	----	--0	--0	---191K	----	----	--0	335.80%191K	--0
-Change in other working capital	-225.75%-8.4M	60.80%-1.42M	73.43%-705K	-126.74%-3.44M	-3,560.98%-2.84M	2,873.03%6.68M	-1,497.68%-3.62M	-1,442.44%-2.65M	7,717.75%12.87M	151.57%82K
Cash from discontinued investing activities
Operating cash flow	19.67%-32.61M	61.37%-4.59M	50.19%-7.21M	-3,504.29%-10.92M	29.05%-9.9M	5.32%-40.6M	6.34%-11.87M	-16.55%-14.47M	97.10%-303K	-90.43%-13.95M
Investing cash flow
Cash flow from continuing investing activities	78.70%-769K	61.78%-198K	88.69%-221K	83.62%-182K	-500.00%-168K	-625.10%-3.61M	-90.44%-518K	-1,815.69%-1.95M	-900.90%-1.11M	-115.38%-28K
Net PPE purchase and sale	78.70%-769K	61.78%-198K	88.69%-221K	83.62%-182K	-500.00%-168K	-625.10%-3.61M	-90.44%-518K	-1,815.69%-1.95M	-900.90%-1.11M	-115.38%-28K
Cash from discontinued investing activities
Investing cash flow	78.70%-769K	61.78%-198K	88.69%-221K	83.62%-182K	-500.00%-168K	-625.10%-3.61M	-90.44%-518K	-1,815.69%-1.95M	-900.90%-1.11M	-115.38%-28K
Financing cash flow
Cash flow from continuing financing activities	267.34%58.43M	622.37%9.07M	-99.63%41K	-79.74%692K	30,480.50%48.62M	-85.46%15.91M	3,205.26%1.26M	4,113.04%11.08M	-96.90%3.42M	129.55%159K
Net issuance payments of debt	--40M	--0	--0	--0	--40M	--0	--0	--0	--0	--0
Net common stock issuance	16.45%18.33M	807.25%8.88M	-99.47%59K	-81.52%675K	--8.71M	-85.90%15.74M	--979K	--11.11M	--3.65M	--0
Proceeds from stock option exercised by employees	-60.63%100K	100.00%48K	-97.14%2K	4,900.00%50K	--0	23.90%254K	-7.69%24K	159.26%70K	-99.24%1K	657.14%159K
Net other financing activities	----	----	80.39%-20K	---33K	---90K	96.30%-88K	2,008.33%253K	66.34%-102K	----	----
Cash from discontinued financing activities
Financing cash flow	267.34%58.43M	622.37%9.07M	-99.63%41K	-79.74%692K	30,480.50%48.62M	-85.46%15.91M	3,205.26%1.26M	4,113.04%11.08M	-96.90%3.42M	129.55%159K
Net cash flow
Beginning cash position	-17.82%130.53M	6.80%151.29M	7.93%158.68M	16.60%169.09M	-17.82%130.53M	71.20%158.83M	-17.51%141.66M	-20.33%147.01M	70.80%145.01M	71.20%158.83M
Current changes in cash	188.51%25.05M	138.54%4.29M	-38.09%-7.39M	-620.29%-10.41M	378.99%38.56M	-142.85%-28.3M	13.75%-11.13M	58.19%-5.35M	-97.99%2M	-75.45%-13.82M
End cash Position	19.19%155.58M	19.19%155.58M	6.80%151.29M	7.93%158.68M	16.60%169.09M	-17.82%130.53M	-17.82%130.53M	-17.51%141.66M	-20.33%147.01M	70.80%145.01M
Free cash flow	24.49%-33.38M	61.39%-4.78M	54.77%-7.43M	-685.22%-11.1M	27.99%-10.07M	-1.92%-44.21M	4.30%-12.39M	-31.21%-16.43M	86.62%-1.41M	-90.48%-13.98M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall